Company page

Seikagaku Corporation

Seikagaku Corporation, traded under the ticker 4548, is a public company based in Japan with a market capitalization of approximately 253 million USD. The company focuses on the development and commercialization of glycoscience-based products, particularly in the fields of pharmaceuticals and medical devices. Seikagaku aims to improve patient outcomes through innovative therapies and solutions.